Suscribirse

Differentiating between active and latent tuberculosis with chest computed tomography - 26/06/21

Doi : 10.1016/j.diii.2021.05.011 
Sébastien Bommart a, b, , Jeremy Charriot b, c, Nicolas Nagot d, Hélène Vernhet-Kovacsik a, Marie P. Revel e, f, Clément Boissin c, Arnaud Bourdin b, c, Edouard Tuaillon g, h
a Department of Radiology, CHU Montpellier, avenue Doyen Gaston Giraud, 34000 Montpellier, France 
b PhyMedExp Inserm U1046, UMR9214 CNRS, 34000 Montpellier, France 
c Department of Respiratory Diseases, CHU Montpellier, 34000 Montpellier, France 
d Department of Biostatistics, CHU Montpellier, 34000 Montpellier, France 
e Department of Radiology, Cochin Hospital, Assistance Publique-Hopitaux de Paris, 75014 Paris, France 
f Université de Paris, Faculté de Médecine, 75006 Paris, France 
g UMR1058 Inserm, 34000 Montpellier, France 
h Department of Bacteriology-Virology, CHU Montpellier, 34000 Montpellier, France 

Corresponding author at: Department of Radiology, CHU Montpellier, avenue Doyen Gaston Giraud, 34000 Montpellier, France.Department of Radiology, CHU Montpellieravenue Doyen Gaston GiraudMontpellier34000France
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Saturday 26 June 2021
This article has been published in an issue click here to access

Highlights

Chest computed tomography may be considered to look for disease activity in patients with tuberculosis.
In patients with positive interferon-γ release assay (IGRA), CT better identifies active tuberculosis than quantitative IGRA testing.
“Tree-in-bud” pattern, consolidation and non-calcified pulmonary nodules are CT features associated with active tuberculosis.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to evaluate the capabilities of chest computed tomography (CT) in distinguishing between active and latent tuberculosis in patients positive for interferon-gamma release assay (IGRA) testing, and to compare the performance of CT with that of quantitative IGRA testing in a low incidence setting.

Materials and methods

Patients with latent or active tuberculosis define by an IGRA positive test were retrospectively recruited. Sensitivity, specificity and accuracy were determined for CT variables and quantitative IGRA results. Final diagnosis of active tuberculosis was based on clinical data and microbiological culture. Univariable and multivariable analyses were performed using logistic regression model to identify CT variables associated with the diagnosis of active tuberculosis.

Results

A total of 92 patients with positive IGRA results who underwent CT examination were included. There were 54 men and 38 women with a mean age of 53.5±18 (SD) years (range: 40–68 years). Of them, 22 patients (24%) had positive Mycobacterium tuberculosis culture and 70 (76%) had latent tuberculosis. Among CT variables, consolidation had the greatest sensitivity (77%; 95%CI: 60–95%) and “tree-in-bud” the greatest specificity (97%; 95% CI: 93–100%) for the diagnosis of active tuberculosis. At univariable analysis “tree-in-bud”, splenic calcification and non-calcified lung nodules were the significant variables independently associated with active tuberculosis. At multivariable analysis, the adjusted odds ratio of “tree-in-bud” was 42.91 (95% CI: 5.62–327.42). Using an optimal threshold of 51 spots, quantitative IGRA yielded 64% sensitivity (95% CI: 44–84%) and 61% specificity (95% CI: 50–73%) for the diagnosis of active tuberculosis.

Conclusions

In a low incidence setting, chest CT, especially when “tree-in-bud” pattern is present, is superior to quantitative IGRA testing to identify patients with active tuberculosis among those with positive IGRA testing.

El texto completo de este artículo está disponible en PDF.

Keywords : Tuberculosis, Latent tuberculosis, Multidetector computed tomography, Interferon-gamma release tests

Abbreviations : CI, CT, HR, IGRA, SD, WHO


Esquema


© 2021  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.